Nara Medical University, with the support of Eli Lilly Japan Co., Ltd., has developed a questionnaire survey method (DTBQ) for measuring the burden of drug therapy for type 2 diabetic patients, and has developed diabetic drug therapy for 236 adult patients. We conducted a test on the feeling of burden and satisfaction.

 In recent years, the number of diabetic patients has increased remarkably worldwide, and many therapeutic agents and methods have been developed.Therefore, it is desired to select a therapeutic drug / treatment method that suits the lifestyle in consideration of the patient's intention and burden.

 Currently, questionnaires (PAID and DDS) are being developed to evaluate the burden felt by diabetic patients, and although the burden associated with diabetes can be comprehensively evaluated, the burden felt by patients on drug treatment is evaluated. That is difficult.Therefore, this time, we developed and verified a questionnaire survey method (DTBQ) to evaluate the burden on patients.

 As a result of the analysis, we confirmed the reliability of the answers and the high reproducibility of the two answers.Regarding the feeling of burden, by administration method and frequency of administration, taking oral medicine once a week, taking oral medicine once a day, taking injection medicine once a week, taking oral medicine multiple times a day It turned out that the burden on the patient became heavier in order.

 In addition, patients with HbA1c (hemoglobin A1c) levels of 7.0% or more feel the burden of drug therapy than patients with HbA7.0c (hemoglobin AXNUMXc) levels of less than XNUMX%, and patients with experience are more burdened with treatment than patients with no experience of hypoglycemia. The feeling was high.Regarding the frequency of administration, the burden of treatment was light for patients with good compliance for both injectable and oral hypoglycemic agents.

 Professor Hitoshi Ishii of the same university needs to consider various treatment burdens based on the patient's lifestyle, in addition to the patient's blood glucose level, HbA2c level, and the effect of drug therapy when deciding on a treatment method for type 1 diabetes. State that there is.In addition, the questionnaire developed this time will help determine an appropriate treatment policy based on patient understanding.

reference:[Nara Medical University] Survey on the burden and satisfaction of drug therapy for type 2 diabetic patients Development of DTBQ and announcement of test results (PDF)

Nara Medical University

University Journal Online Editorial Department

This is the online editorial department of the university journal.
Articles are written by editorial staff who have a high level of knowledge and interest in universities and education.